Radiation therapy enhances anti-tumor activity of a MET CAR T-based immunotherapy approach for glioblastoma multiforme.

被引：0
|
作者：
Hovhannisyan, Lusine [1 ,2 ]
Aebersold, Daniel M. [1 ]
Maher, John [3 ]
Ochsenbein, Adrian F. [2 ,4 ]
Riether, Carsten [2 ,4 ]
Medova, Michaela [1 ,2 ]
Zimmer, Yitzhak [1 ,2 ]
机构：
[1] Univ Bern, Dept Radiat Oncol, Inselspital, Bern, Switzerland
[2] Univ Bern, Dept BioMed Res, Bern, Switzerland
[3] Kings Coll London, Fac Life Sci & Med, London, England
[4] Univ Bern, Univ Hosp Bern, Dept Med Oncol, Inselspital, Bern, Switzerland
来源：
CLINICAL CANCER RESEARCH | 2021年 / 27卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-039
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Sub-lethal radiation enhances anti-tumor immunotherapy in a transgenic mouse model of pancreatic cancer
    Zhu Alexander Cao
    Dylan Daniel
    Douglas Hanahan
    BMC Cancer, 2
  • [22] T cells conditioned with MDSC show an increased anti-tumor activity after adoptive T cell based immunotherapy
    Raber, Patrick L.
    Sierra, Rosa A.
    Thevenot, Paul T.
    Zhang Shuzhong
    Wyczechowska, Dorota D.
    Kumai, Takumi
    Celis, Esteban
    Rodriguez, Paulo C.
    ONCOTARGET, 2016, 7 (14) : 17565 - 17578
  • [23] CD73 targeting therapy enhances the anti-tumor effect of radiation therapy in rectal cancer
    Tsukui, Hidenori
    Horie, Hisanaga
    Saito, Akira
    Koinuma, Koji
    Ohsawa, Hideyuki
    Yamaguchi, Hironori
    Sakuma, Yasunaru
    Hosoya, Yoshinori
    Yoshimura, Kotaro
    Lefor, Alan
    Sata, Naohiro
    Kitayama, Joji
    CANCER RESEARCH, 2020, 80 (16)
  • [24] Electroporation of TCR encoding RNA into T cells as a new approach for anti-tumor immunotherapy
    Schaft, N.
    Doerrie, J.
    Birkholz, K.
    Hoyer, S.
    Wellner, V.
    Mueller, I.
    Kaempgen, E.
    Schuler, G.
    EXPERIMENTAL DERMATOLOGY, 2007, 16 (03) : 220 - 220
  • [25] GLUT1 overexpression enhances CAR T cell metabolic fitness and anti-tumor efficacy
    Shi, Yuzhe
    Kotchetkov, Ivan S.
    Dobrin, Anton
    Hanina, Sophie A.
    Rajasekhar, Vinagolu K.
    Healey, John H.
    Sadelain, Michel
    MOLECULAR THERAPY, 2024, 32 (07) : 2393 - 2405
  • [26] Comprehensive cyclic immunofluorescent analysis reveals new target candidates for CAR T cell based immunotherapy of glioblastoma multiforme
    Reiss, Sandy
    Tomiuk, Stefan
    Kollet, Jutta
    Drewes, Jan
    Jungblut, Melanie
    Bosio, Andreas
    CANCER RESEARCH, 2020, 80 (16)
  • [27] Gemcitabine synergistically enhances anti-tumor effects of recombinant immunogen-based cancer immunotherapy
    Liu, Shih-Jen
    Chang, Li-Sheng
    Yan, Wan-Lun
    Yeh, Yi-Chen
    Leng, Chih-Hsiang
    ANNALS OF ONCOLOGY, 2015, 26 : 101 - 101
  • [28] A novel chimeric Fas signal redirect receptor enhances the durability of anti-tumor activity and serial killing potential of CAR T cells
    Ecker, Christopher
    Peralta, Eigen
    Chu, Hui-Yi
    Loter, Lorraine
    Tsuda, Masanao
    Avramis, Earl
    Denholtz, Matthew
    Witty, Alec
    Lee, Tom
    Valamehr, Bahram
    CANCER RESEARCH, 2024, 84 (06)
  • [29] Radiation enhances the anti-tumor effects of vaccinia-p53 gene therapy in glioma
    Timiryasova, TM
    Gridley, DS
    Chen, B
    Andres, ML
    Dutta-Roy, R
    Miller, G
    Bayeta, EJM
    Fodor, I
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2003, 2 (03) : 223 - 235
  • [30] Targeting Phosphatidylserine Enhances the Anti-tumor Response to Tumor-Directed Radiation Therapy in a Preclinical Model of Melanoma
    Budhu, Sadna
    Giese, Rachel
    Gupta, Aditi
    Fitzgerald, Kelly
    Zappasodi, Roberta
    Schad, Sara
    Hirschhorn, Daniel
    Campesato, Luis Felipe
    De Henau, Olivier
    Gigoux, Mathieu
    Liu, Cailian
    Mazo, Gregory
    Deng, Liang
    Barker, Christopher A.
    Wolchok, Jedd D.
    Merghoub, Taha
    CELL REPORTS, 2021, 34 (02):
12345